VELSIPITY

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: ebef6dbc552e0c08
Drug Approval Canada Name: VELSIPITY
Product Name: VELSIPITY
Status: Marketed
Status Date: 2024-04-18
Original Market Date: 2024-04-18
Din: 02544903
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 56:44.00
Atc Original: L04AE05 ETRASIMOD
Atc Name: l 04 ae 05
Aig Number: 0165723001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

ETRASIMOD (ETRASIMOD L-ARGININE)

2 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ebef6dbc552e0c08

Type

Standard